Chinese english Germany Japanese Korea

IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate)

IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate) Struktur
CAS-Nr.
Englisch Name:
IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate)
Synonyma:
IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate)
CBNumber:
CB12647794
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate) Eigenschaften

Sicherheit

IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate) Chemische Eigenschaften,Einsatz,Produktion Methoden

IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-83725681-603
China 4505 50
  • IMp. C (EP) as Hydrogen Sulfate: Methyl(2R)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]- pyridin-5(4H)-yl]acetate Hydrogen Sulfate((R)-Clopidogrel Hydrogen Sulfate)
Copyright 2019 © ChemicalBook. All rights reserved